Insulin supplemented infant formula

a technology of infant formula and supplementation, which is applied in the direction of drug composition, peptide/protein ingredients, metabolic disorders, etc., can solve the problems of low immunologically recognizable which are attempting to mimic as much as possible breast milk, and the level of active insulin in infant formulas is probably zero, and the level of active insulin in infant formulas is expected to be zero
US20020064549A1Inactive Publication Date: 2002-05-30NUTRINIA LTD
0 Cites 19 Cited by

Patent Information

Authority / Receiving Office
US · United States
Current Assignee / Owner
NUTRINIA LTD
Publication Date
2002-05-30
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

An infant formula in a powder or solution form including nutritional components and an insulin supplement. A method of feeding an infant including the steps of dissolving an infant formula powder containing nutritional components and an insulin supplement in water for obtaining a solution including said nutritional components and said insulin supplement and feeding the infant with the solution.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a continuation in part of U.S. patent application Ser. No. 09 / 701,652 filed in Nov. 30, 2000.FIELD AND BACKGROUND OF THE INVENTION

[0002] The present invention relates to an infant formula and, more particularly, to an insulin supplemented infant formula.

[0003] Breastfeeding, the natural feeding mode, has multiple beneficial effects on the infant. First, it is known to be the most suitable diet for infant's nutritional requirements. Second, it provides the infant with immune protection against a wide range of infection related diseases (1). Third, as it contains active insulin molecules it protects the infant against the development of Type-1 diabetes (2-3). Fourth, insulin present in milk enhances small intestinal growth and development (4).

[0004] Type-1 diabetes, which is insulin dependent diabetes mellitus (IDDM), is the consequence of progressive autoimmune pancreatic .beta. cell destruction during an initially asymptomatic period that may extend many y...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More